A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma

Name: A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma
Published: 2013
License: Public Domain

Tracon Pharmaceuticals Inc. · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

soft-tissue-sarcoma

advanced soft tissue sarcoma, trc105, cd105, endoglin, angiogenesis inhibitor, sts, soft tissue sarcoma, tki, tyrosine kinase inhibitor, pazopanib, votrient, angiosarcoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 841855
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.